Jinhe Biotechnology Co Ltd Financial Flexibility Index
Jinhe Biotechnology Co Ltd financial flexibility index. Jinhe Biotechnology Co Ltd (002688) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥313.19 Million (operating CF CN¥229.93 Million minus capex CN¥83.27 Million) represents 0% of total liabilities (CN¥2.99 Billion). See cash generation quality of Jinhe Biotechnology Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jinhe Biotechnology Co Ltd (2008–2024)
Financial flexibility index of Jinhe Biotechnology Co Ltd from 2008 to 2024. Historical Financial Flexibility Index trend for Jinhe Biotechnology Co Ltd across 17 annual periods. Check 002688 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Jinhe Biotechnology Co Ltd Financial Flexibility Index by Year (2008–2024)
Jinhe Biotechnology Co Ltd financial flexibility index by year from 2008 to 2024. Year-by-year free cash flow to debt coverage for Jinhe Biotechnology Co Ltd. For the full cash flow conversion analysis, see Jinhe Biotechnology Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥860.66 Million | CN¥498.42 Million | CN¥3.15 Billion | ▲ +22.3% |
| 2023 | 0.22x | CN¥655.98 Million | CN¥198.77 Million | CN¥2.94 Billion | ▼ -11.8% |
| 2022 | 0.25x | CN¥526.63 Million | CN¥124.47 Million | CN¥2.08 Billion | ▼ -35.5% |
| 2021 | 0.39x | CN¥536.70 Million | CN¥152.98 Million | CN¥1.37 Billion | ▲ +38.1% |
| 2020 | 0.28x | CN¥462.09 Million | CN¥258.08 Million | CN¥1.63 Billion | ▼ -5.3% |
| 2019 | 0.30x | CN¥461.03 Million | CN¥282.19 Million | CN¥1.54 Billion | ▲ +62.4% |
| 2018 | 0.18x | CN¥287.35 Million | CN¥117.17 Million | CN¥1.56 Billion | ▲ +9.1% |
| 2017 | 0.17x | CN¥223.82 Million | CN¥27.25 Million | CN¥1.32 Billion | ▼ -56.7% |
| 2016 | 0.39x | CN¥420.98 Million | CN¥292.41 Million | CN¥1.08 Billion | ▼ -9.2% |
| 2015 | 0.43x | CN¥357.05 Million | CN¥214.97 Million | CN¥830.68 Million | ▼ -16.8% |
| 2014 | 0.52x | CN¥290.51 Million | CN¥-58.02 Million | CN¥562.50 Million | ▼ -80.5% |
| 2013 | 2.64x | CN¥308.87 Million | CN¥148.32 Million | CN¥116.81 Million | ▲ +199.9% |
| 2012 | 0.88x | CN¥123.31 Million | CN¥88.81 Million | CN¥139.83 Million | ▲ +103.2% |
| 2011 | 0.43x | CN¥146.02 Million | CN¥106.59 Million | CN¥336.44 Million | ▼ -7.3% |
| 2010 | 0.47x | CN¥172.84 Million | CN¥118.05 Million | CN¥369.09 Million | ▲ +328.3% |
| 2009 | 0.11x | CN¥46.20 Million | CN¥23.20 Million | CN¥422.56 Million | ▲ +8.6% |
| 2008 | 0.10x | CN¥39.14 Million | CN¥11.64 Million | CN¥388.63 Million | — |